CAT# | CPM-1-0550 |
Sequence | SSVDEQIQW |
Size | 50 Test, 100 Test | Antigen | Virus | Epitope Origin | SIV gag | MHC Restriction | Mamu-A_90120-5 | Conjugate | APC |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0306 | HLA-A_24_02 Influenza PB1498-505 tetramer-RYGFVANF-APC labeled | Inquiry | ||
CPM-1-0054 | HLA-A_02_01 EBV LMP2 243-251 tetramer-TVCGGIMFL-PE labeled | Inquiry | ||
CPM-1-0617 | HLA-A_02_01 EBV BALF4 tetramer-FLDKGTYTL-BV421 labeled | Inquiry | ||
CPM-1-0344 | H-2Db HPV 16 E7 tetramer-RAHYNIVTF-BV421 labeled | Inquiry | ||
CPM-1-0635 | HLA-B_35_01 Influenza NP tetramer-LPFEKSTVM-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The peptide st-Ht31 P, A-kinase anchoring protein (AKAP) inhibitor, has the negative control for st-Ht31. In DRG ...
Norleual is a potent inhibitor of the HGF/Met system, which inhibited the prosurvival effects of HGF and suppres ...
Orexin A (OXA) and orexin B (OXB) are hypothalamic neuropeptides discovered in 1998, which bind to two G-protein ...
Urantide is a UⅡ receptor antagonist. It can effectively alleviate monocrotaline (MCT)-induced PAH in a rat mode ...
GR 64349 is a selective and potent NK2 agonist (EC50 = 3.7 nM in rat colon) with activity comparable to that of ...